CAPONE, Marta Luciana
CAPONE, Marta Luciana
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs.
2008-01-01 Capone, Marta Luciana; Tacconelli, Stefania; Nulll, nullDi Francesco; Petrelli, M; Patrignani, Paola
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease
2006-01-01 Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, Maria Gina; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Price, T. S; Patrono, C; DE CATERINA, Raffaele; Patrignani, Paola
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.
2003-01-01 Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania
Clinical pharmacology of selective COX-2 inhibitors.
2003-01-01 Capone, Marta Luciana; Tacconelli, Stefania; Sciulli, Maria Gina; Patrignani, Paola
Determinants of platelet activation in human essential hypertension.
2004-01-01 Minuz, P; Patrignani, Paola; Gaino, S; Seta, F; Capone, Marta Luciana; Tacconelli, Stefania; Degan, M; Faccini, G; Fornasiero, A; Talamini, G; Tommasoli, R; Arosio, E; Santonastaso, Cl; Lechi, A; Patrono, Carlo
Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
2010-01-01 Bruno, Annalisa; Di Francesco, L; Coletta, I; Mangano, G; Alisi, Ma; Polenzani, L; Milanese, C; Anzellotti, P; Ricciotti, Emanuela; Dovizio, Melania; Di Francesco, A; Tacconelli, Stefania; Capone, Marta Luciana; Patrignani, Paola
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease
2006-01-01 Sciulli, Mg; Renda, Giulia; Capone, Marta Luciana; Tacconelli, Stefania; Ricciotti, Emanuela; Manarini, S; Evangelista, V; Rebuzzi, A; Patrignani, Paola
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes
2005-01-01 Sciulli, Maria Gina; Renda, Giulia; Capone, Marta Luciana; Tacconelli, Stefania; Ricciotti, Emanuela; Rebuzzi, A. G.; Patrignani, Paola
INIBITORI SELETTIVI DI COX-2: LE NUOVE MOLECOLE
2004-01-01 Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences
2011-01-01 Anzellotti, Paola; Capone, Marta Luciana; Jeyam, A; Tacconelli, Stefania; Bruno, Annalisa; Tontodonati, P; DI FRANCESCO, Luigia; Grossi, L; Renda, Giulia; Merciaro, G; Di Gregorio, P; Price, Ts; Garcia Rodriguez, La; Patrignani, Paola
Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation
2010-01-01 Tacconelli, Stefania; Capone, Marta Luciana; Patrignani, Paola
New insights into COX-2 biology and inhibition.
2005-01-01 Patrignani, Paola; Tacconelli, Stefania; Sciulli, Maria Gina; Capone, Marta Luciana
NSAIDs and cardiovascular disease.
2008-01-01 Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population.
2010-01-01 Capone, Marta Luciana; Tacconelli, Stefania; Rodriguez, Lg; Patrignani, Paola
Platelet activation in patients with colorectal cancer.
2005-01-01 Sciulli, Maria Gina; Filabozzi, P; Tacconelli, Stefania; Padovano, R; Ricciotti, Emanuela; Capone, Marta Luciana; Grana, Marilena; Carnevale, V; Patrignani, Paola
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease.
2018-01-01 Tacconelli, S; Dovizio, M; Di Francesco, L; Meneguzzi, A; D'Agostino, I; Evangelista, V; Manarini, S; Capone, Ml; Grossi, L; Porreca, E; Di Febbo, C; Bruno, A; Ballerini, P; Levantesi, G; Fava, C; Minuz, P; Patrignani, P.
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance"
2008-01-01 Patrignani, Paola; Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, M; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Patrono, C; DE CATERINA, Raffaele
Risk management profile of etoricoxib: An example of personalized medicine
2008-01-01 Patrignani, Paola; P., Email Author; Tacconelli, S.; Capone, M. L.
The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity.
2002-01-01 Tacconelli, Stefania; Capone, Marta Luciana; Sciulli, Maria Gina; Ricciotti, Emanuela; Patrignani, Paola
“DIARILISOSSAZOLI FUNZIONALIZZATI INIBITORI DELLA CICLOSSIGENASI”
2008-01-01 Scilimati, A; DI NUNNO, L; Vitale, P; Patrignani, Paola; Tacconelli, Stefania; Capone, Marta Luciana
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs. | 2008 | Capone, Marta Luciana; Tacconelli, Stefania; Nulll, nullDi Francesco; Petrelli, M; Patrignani, Paola | |
| Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease | 2006 | Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, Maria Gina; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Price, T. S; Patrono, C; DE CATERINA, Raffaele; Patrignani, Paola | |
| Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. | 2003 | Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania | |
| Clinical pharmacology of selective COX-2 inhibitors. | 2003 | Capone, Marta Luciana; Tacconelli, Stefania; Sciulli, Maria Gina; Patrignani, Paola | |
| Determinants of platelet activation in human essential hypertension. | 2004 | Minuz, P; Patrignani, Paola; Gaino, S; Seta, F; Capone, Marta Luciana; Tacconelli, Stefania; Degan, M; Faccini, G; Fornasiero, A; Talamini, G; Tommasoli, R; Arosio, E; Santonastaso, Cl; Lechi, A; Patrono, Carlo | |
| Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro. | 2010 | Bruno, Annalisa; Di Francesco, L; Coletta, I; Mangano, G; Alisi, Ma; Polenzani, L; Milanese, C; Anzellotti, P; Ricciotti, Emanuela; Dovizio, Melania; Di Francesco, A; Tacconelli, Stefania; Capone, Marta Luciana; Patrignani, Paola | |
| Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease | 2006 | Sciulli, Mg; Renda, Giulia; Capone, Marta Luciana; Tacconelli, Stefania; Ricciotti, Emanuela; Manarini, S; Evangelista, V; Rebuzzi, A; Patrignani, Paola | |
| Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes | 2005 | Sciulli, Maria Gina; Renda, Giulia; Capone, Marta Luciana; Tacconelli, Stefania; Ricciotti, Emanuela; Rebuzzi, A. G.; Patrignani, Paola | |
| INIBITORI SELETTIVI DI COX-2: LE NUOVE MOLECOLE | 2004 | Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania | |
| Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences | 2011 | Anzellotti, Paola; Capone, Marta Luciana; Jeyam, A; Tacconelli, Stefania; Bruno, Annalisa; Tontodonati, P; DI FRANCESCO, Luigia; Grossi, L; Renda, Giulia; Merciaro, G; Di Gregorio, P; Price, Ts; Garcia Rodriguez, La; Patrignani, Paola | |
| Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation | 2010 | Tacconelli, Stefania; Capone, Marta Luciana; Patrignani, Paola | |
| New insights into COX-2 biology and inhibition. | 2005 | Patrignani, Paola; Tacconelli, Stefania; Sciulli, Maria Gina; Capone, Marta Luciana | |
| NSAIDs and cardiovascular disease. | 2008 | Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania | |
| NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population. | 2010 | Capone, Marta Luciana; Tacconelli, Stefania; Rodriguez, Lg; Patrignani, Paola | |
| Platelet activation in patients with colorectal cancer. | 2005 | Sciulli, Maria Gina; Filabozzi, P; Tacconelli, Stefania; Padovano, R; Ricciotti, Emanuela; Capone, Marta Luciana; Grana, Marilena; Carnevale, V; Patrignani, Paola | |
| Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. | 2018 | Tacconelli, S; Dovizio, M; Di Francesco, L; Meneguzzi, A; D'Agostino, I; Evangelista, V; Manarini, S; Capone, Ml; Grossi, L; Porreca, E; Di Febbo, C; Bruno, A; Ballerini, P; Levantesi, G; Fava, C; Minuz, P; Patrignani, P. | |
| Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" | 2008 | Patrignani, Paola; Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, M; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Patrono, C; DE CATERINA, Raffaele | |
| Risk management profile of etoricoxib: An example of personalized medicine | 2008 | Patrignani, Paola; P., Email Author; Tacconelli, S.; Capone, M. L. | |
| The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity. | 2002 | Tacconelli, Stefania; Capone, Marta Luciana; Sciulli, Maria Gina; Ricciotti, Emanuela; Patrignani, Paola | |
| “DIARILISOSSAZOLI FUNZIONALIZZATI INIBITORI DELLA CICLOSSIGENASI” | 2008 | Scilimati, A; DI NUNNO, L; Vitale, P; Patrignani, Paola; Tacconelli, Stefania; Capone, Marta Luciana |